This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:sjogrens [01.02.2019] – [Patient experiences and discussion from Study Site topic(s)] sallieq | home:diseases:sjogrens [01.02.2019] – [Recent Research] sallieq | ||
---|---|---|---|
Line 99: | Line 99: | ||
The aOR for those suffering from at least one rheumatologic disease was 1.56 (95% CI: 1.26-1.93), those with two rheumatologic diseases was 1.98 (95% CI: 1.29-3.04), while those with three or more rheumatologic diseases was 7.86 (95% CI: 1.09-56.58). | The aOR for those suffering from at least one rheumatologic disease was 1.56 (95% CI: 1.26-1.93), those with two rheumatologic diseases was 1.98 (95% CI: 1.29-3.04), while those with three or more rheumatologic diseases was 7.86 (95% CI: 1.09-56.58). | ||
- | ===== recent research | + | ===== Recent Research |
According to literature, Sjogren' | According to literature, Sjogren' | ||
Line 106: | Line 106: | ||
+ | | ||
+ | |||
+ | | ||
+ | |||
+ | pSS patients have impaired blood pressure response to standing. Dysautonomia correlates with PSS-associated symptoms and quality of life. | ||
+ | |||
+ | This information aids understanding of the history and development of dry eye research, in addition to the impact and characteristics of the contributors to the field. | ||
+ | |||
+ | |||
+ | Primary Sjögren' | ||
+ | | ||
+ | Abnormalities of memory B cells seem to be closely involved in the pathogenesis of primary Sjögrens Syndrome (pSS) and its malignant complication, | ||
+ | |||
+ | The presence of Sjögren' | ||